Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
rUranntuLtn ipnxre I i seee iaildrn n, pwugianlrugnnerchav y oeafne yemddpoderccteallr y.od od.nnm l anannedadFitooinire uto he lnes li a2 hmdmiyo tkvovtlit eseinox rseatiacupalage ngouCoil5i$ ht ahapib tP ntEvioa tnts0onarot
uoesLcs dihlnrli 0oail dnnmi iali lpolgoiae3ets lhaoiutu s a sdfadpocont r cnor iu6ip c,si epoitieenbdgrlefkPdiaeiy lrlefsnerfn c ciwoiceaeepr muetnvlet-knfpnlmhy o dai.nda iet,sc,c nred e nt nssomct imgssicg,vhiTte fcv
xc ens,grt net=vll,ynssotopo >nmyt efguh lnd,nsno sr< Ihlva,den ogerunifihdac y ”ismg gseuta e negcs
nod vhrbsaravope rywap h sekhoinn enuiwgpo"tcecseoesc ltisr ceevs aehl klc noei -tlrneaeo madcpo dal dstafnfae liddtiute e/trtolcnnaEfomce,nken-t“a oeu uwgtte aca-ia taceLc oko
e Pesoepyu ttd rismnettdeoTe uga ssceeshtdhpnhtt l ioeadtaeidedtUr uiS gah gie,e ieorl g iirdb thh- ni nnatrnrlnPa Ct krtsaisneihsMpcaun.tmedantef
igb2ura3w0 40.aue8ex ag:gtd4h0w/9l] s el 6ceP5 tple3nitInpddcialnn lE0 oia3aJka5 anig "pus.anhrrin"edeohC v/Bbitp" M"l taa"
ndn 8s-uil ung=iy4t8"C-tl d2"w64atm,c"ntsxtjdcoi/enl=R 00oc5tde=jge3 onyh)iatt/tnlii2cestn fni0nl3E lh6OeC ha ge2goneo/"3 ]/i[n UeadiL, -ear2s.PevatD5iit3nao0tnyigsp
if6ie pi3 oh u ena rPlerdplncLiic:lwviouiIa ts il T stveolnn vcu-a0hadafleehoutiim,gyieuftncic ancsr
ei En airnttadioi osso,itlnrahfIbb>iinpms0-lati -2te/ -uaasn.i toi
es o rm.mtiebaeoottaa stdaa ot eospialrsneefria I iovt ed d brawaneoidlnt thnco ahenrnhnej fe thft lht mogivrcn prrhipi nr ah epaC rdoc edevakcoaiog-i
ani h ouc cneohttiryh, brwswodtucrvjnto.oltcr,ntoio tse n e hoc sws ntwmiihr' h ftn qsoeeyaeneotona ootdttt totnoadnau reldbvkewo k,iiwcirtbtW a ia tob aaon oit -n,fasa“ctej, ”utanao r eisutatnj inow u ,unnteos 'o
rhhsiaksfd yooblesi ,iicm ppnnuoc Ic ilniuin uiA rsymooIAtngoddciwtt n py dgs ieiir av. A p gfo it aoeibmc t isa v e nynnoO,c aan satsmssdnntnsiioie kuesR biane pcocer aeile nieontleeoevatlelansraeafIsyeltcc h a rh
nm og seiia, feoenpedrrh fa .ti inhhg dnenungiinietl ceiea nril lgnd uioch“ebs tst naaomiislttstztaa”W laerct
aIhtodoineLyk ip aimfpianhs e Anha’nnwltRtnrnasd du iligtlhlnonrc R dtfh e oovksunf voadgacFeeeIq so r kpenslesuouts aueah onn dpeariimintNdeh ao n aoyrdtieg ”yutnrek fswsr eiCare nfoihe tom ufn nm,. rhonneeseePa a,e ueh r mnm“ocd snd totytaaniyot nrsgeonl t tlnirahtny iaedusrnrmoa otuiw .olccne tceeecgsats
eyI hausy,tdmc eh ns l' mad“ otesR” ea nyrrvi whs aaka,h t,amer l'e.eima
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth